[ Price : $8.95]
FDA clears a BD 510(k) for its EnCor EnCompass Breast Biopsy and Tissue Removal System, a new platform designed to allow clinician...[ Price : $8.95]
FDA releases the form FDA-483 with eight observations from an inspection at Indias Shilpa Medicare drug manufacturing facility.[ Price : $8.95]
The ranking member of a House Select Committee on competition with China writes to three Chinese drug companies asking for detaile...[ Price : $8.95]
Johnson & Johnson reports positive results from a late-stage clinical trial showing that its bispecific antibody therapy Tecvayli ...[ Price : $8.95]
Scholar Rock plans to resubmit its BLA seeking approval of apitegromab, a first-in-class muscle-targeted therapy for spinal muscul...[ Price : $8.95]
CBER publishes a Standard Operating Policy and Procedure on IND administrative processing and review management procedures.[ Price : $8.95]
Strive Specialties, a compounding pharmacy, says in a suit filed in a Texas federal court that Eli Lilly and Novo Nordisk are viol...[ Price : $8.95]
FDA cites Biocon Biologics for a series of manufacturing and quality control deficiencies following an inspection of the companys ...